MedTrace Logo

First Optical Coherence Microscopy in Dermato-oncology

NCT03079232 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 122

Last updated 2025-02-10

No results posted yet for this study

Summary

OCTAV is a medical device class I, not CE marked, based on a new technique for high-resolution imager (cell) internal microstructures of all types of biological tissues in vivo or ex vivo, to a depth of penetration 800 .mu.m. It allows to explore the epidermis, the dermo-epidermal junction and middle dermis in a totally non-invasive (direct contact with the tissue without sampling).

Conditions

Interventions

DEVICE

OCTAV Patient

In vivo skin imaging performed by placing the tip of the OCTAV device directly in slight contact with the skin of the patient.

DEVICE

OCTAV Control group

In vivo skin imaging performed by placing the tip of the OCTAV device directly in slight contact with the skin of the patient.

Sponsors & Collaborators

  • DAMAE Médical

    collaborator OTHER

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Jean-Luc PERROT, MD · CHU SAINT-ETIENNE

  • Cécile DUPONT, PhD · Damae Medical

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-28
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03079232 on ClinicalTrials.gov